Skip to main content

Table 3 The relationship between no. 12b, 13, and 14v LNs involvement and clinicopathological factors

From: Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: a randomized controlled study

Clinicopathological

factors

No.12b

P value

No.13

P value

No.14v

P value

+

−

+

−

+

−

T category

 

0.625

 

0.382

 

0.304

 T1–2

0

6

0

6

0

6

 T3–4

1

25

3

23

4

22

No. 6 LNs

 

0.340

 

0.087

 

0.045

 Negative

0

15

0

15

0

15

 Positive

1

16

3

14

4

13

Duodenum involvement

 

0.370

 

0.039

 

0.419

 No

1

17

0

18

3

15

 Yes

0

14

3

11

1

13

Tumor size

 

0.400

 

0.335

 

0.135

 ≥ 5 cm

0

13

2

11

3

10

 < 5 cm

1

18

1

18

1

18

Histological type

 

0.723

 

0.827

 

0.884

 Adenocarcinoma

    

  Poorly

1

13

2

12

2

12

  Well-moderately

0

14

1

13

2

12

 SRCC

0

3

0

3

0

3

 MAC

0

1

0

1

0

1

CA19-9 (U/ml)

 

0.625

 

0.382

 

0.732

 ≥ 37

0

6

0

6

1

5

 < 37

1

25

3

23

3

23

CEA (ng/ml)

 

0.662

 

0.434

 

0.581

  ≥ 5

0

5

0

5

1

4

  < 5

1

26

3

24

3

24

AFP (ng/ml)

 

0.744

 

0.558

 

0.492

  ≥ 10

0

3

0

3

0

3

  < 10

1

28

3

26

4

25

  1. SRCC signet ring cell carcinoma; MAC mucinous adenocarcinoma; CA19-9 carbohydrate antigen 19-9; CEA carcinoembryonic antigen
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us